Sunil R. Hingorani

Fred Hutch Cancer Center

Full Professor(heuristic)

Pancreatic and Hepatic Oncology Research · Oncology

h-index45

i10-index76

Publications245

Citations24,629

Grants

No NSF/NIH grants on record.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0015

PageRank within Oncology co-authorship network

Explore collaboration map

Admission Signals

New paper: Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer (bioRxiv (Cold Spring Harbor Laboratory))2026-04-08
New preprint: Abrogating TGFβ signaling in TCR-engineered T cells and enhancing antigen processing by tumor cells promotes sustained therapeutic activity in pancreatic ductal adenocarcinoma2025-06-08

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0002-3869-8729

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 33

Serial Thermal Ablation Induces Abscopal Antitumor Immunity and Reveals Targetable CSF1R-Dependent Resistance in Pancreatic Cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2026-04-08
Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001
Cancers · 2026-02-03 · 1 citations
Table S1 from Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer–Associated Fibroblasts
2025-12-09
Supplementary Methods from Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer–Associated Fibroblasts
2025-12-09
Table S2 from Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer–Associated Fibroblasts
2025-12-09
Supplementary Figures from Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer–Associated Fibroblasts
2025-12-09
Abstract B112: HMGA2 Predicts Treatment Outcome in Pancreatic Cancer
Cancer Research · 2025-09-28
Abrogating TGFβ signaling in TCR-engineered T cells and enhancing antigen processing by tumor cells promotes sustained therapeutic activity in pancreatic ductal adenocarcinomaPreprint
bioRxiv (Cold Spring Harbor Laboratory) · 2025-06-08 · 1 citations
Improving outcomes of patients with pancreatic cancer
Nature Reviews Clinical Oncology · 2025-05-06 · 35 citations
Supplementary Table S2 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma
2025-02-17
Data from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaPreprint
2025-02-17
Supplementary Figure S5 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaPreprint
2025-02-17
Supplementary Figure S2 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaPreprint
2025-02-17
Supplementary Figure S6 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaPreprint
2025-02-17
Supplementary Table S2 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma
2025-02-17
Supplementary Table S4 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma
2025-02-17
Supplementary Table S5 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma
2025-02-17
Supplementary Figure S2 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaPreprint
2025-02-17
Supplementary Figure S5 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal AdenocarcinomaPreprint
2025-02-17
Supplementary Table S3 from HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma
2025-02-17

Open author page on OpenAlex →